Results 11 to 20 of about 961,635 (194)

Cerebral Creatine Deficiency Syndrome due to GAMT Deficiency - Importance of Meticulous Developmental Screening: A Case Report

open access: yesIndian Pediatrics Case Reports
Background: Cerebral creatine deficiency syndrome (CCDS) is a rare metabolic disorder characterized by creatine deficiency in the brain, leading to developmental delays, intellectual disabilities, and neurological impairments.
Allen David   +3 more
doaj   +3 more sources

Abnormal N-Glycosylation of a Novel Missense Creatine Transporter Mutant, G561R, Associated With Cerebral Creatine Deficiency Syndromes Alters Transporter Activity and Localization

open access: yesBiological and Pharmaceutical Bulletin, 2017
Cerebral creatine deficiency syndromes (CCDSs) are caused by loss-of-function mutations in creatine transporter (CRT, SLC6A8), which transports creatine at the blood-brain barrier and into neurons of the central nervous system (CNS).
Masanori Tachikawa   +2 more
exaly   +5 more sources

P002: Investigating the impact of the 2022 ClinGen missense variant interpretation recommendations for cerebral creatine deficiency syndromes*

open access: yesGenetics in Medicine Open
Cerebral creatine deficiency syndromes (CCDS) are inherited metabolic disorders of creatine synthesis and transport due to pathogenic GAMT, GATM, or SLC6A8 variants, and frequently result in serious neurological impairment.
Emily Groopman   +13 more
doaj   +3 more sources

How a patient-led advocacy organization supports the road to diagnosis and treatment of creatine transporter deficiency [PDF]

open access: yesFrontiers in Neuroscience
The current era of drug development has evolved significantly. Patient advocacy organizations are moving beyond simply supporting community members and are taking the reins to improve the speed of diagnoses, initiate therapeutic discoveries, and lay the ...
Heidi Wallis   +2 more
doaj   +3 more sources

A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism [PDF]

open access: yesScientific Reports, 2021
Creatine is an organic compound used as fast phosphate energy buffer to recycle ATP, important in tissues with high energy demand such as muscle or brain.
Lara Duran-Trio   +9 more
doaj   +2 more sources

[Clinical features and SLC6A8 gene mutations of cerebral creatine deficiency syndrome I: an analysis of two families]. [PDF]

open access: yesZhongguo Dang Dai Er Ke Za Zhi, 2020
This article reports the clinical and genetic features of two cases of cerebral creatine deficiency syndrome I (CCDSI) caused by SLC6A8 gene mutations. Both children were boys. Boy 1 (aged 2 years and 10 months) and Boy 2 (aged 8 years and 11 months) had the clinical manifestations of delayed mental and motor development, and convulsion.
Sun WH   +9 more
europepmc   +4 more sources

Identification of two pathogenic guanidinoacetate methyltransferase variants in patients with intellectual disability: clinical and molecular insights [PDF]

open access: yesMolecular Genetics and Metabolism Reports
Background: Intellectual disability (ID) is a genetically heterogeneous neurodevelopmental disorder with diverse underlying causes. Guanidinoacetate methyltransferase (GAMT) deficiency is a rare autosomal recessive disorder of creatine biosynthesis ...
Seyyed Reza Hashemi   +7 more
doaj   +2 more sources

Creatine transporter deficiency: Novel mutations and functional studies

open access: yesMolecular Genetics and Metabolism Reports, 2016
X-linked cerebral creatine deficiency (MIM 300036) is caused by deficiency of the creatine transporter encoded by the SLC6A8 gene. Here we report three patients with this condition from Israel.
O. Ardon   +12 more
doaj   +2 more sources

Cerebral Creatine Deficiency Disorders

open access: yes, 2017
Cerebral creatine deficiency disorders that result in very low levels of creatine in the brain, can cause in intellectual disability, seizures, expressive speech disorder and behavior disorders if not treated in early childhood.
Sylvia Stockler, Peter W. Schutz
core   +2 more sources

A novel variation of gamt in cerebral creatine deficiency syndrome, first complete homozygous deletion of GAMT

open access: yesGenetika, 2023
Cerebral Creatine Deficiency Syndromes (CCDS) are congenital metabolic disorders in the creatine metabolism pathway. In this study, we evaluated the clinical, phenotypic, radiological and genetic features of patients with CCDS.
H. Ucar   +4 more
semanticscholar   +2 more sources

Home - About - Disclaimer - Privacy